Table 2 Patient characteristics and laboratory measurements after PS matching analysis
Group 1: n (%) or mean [range: min, max] | Group 2: n (%) or mean [range: min, max] | p-value (U-test/Fisher test) | Difference from mean (%) | |
|---|---|---|---|---|
Number | 19 (100) | 19 (100) | ||
Patient characteristics | ||||
ECMO therapy | 4 (21.0) | 4 (21.0) | 1.00 | 0.0 |
KRT | 19 (100) | 19 (100) | 1.00 | 0.0 |
SAPS II d0 | 77 [38, 118] | 75 [48, 100] | 0.644 | 1.7 |
48-h mortality | 1 (5.3) | 3 (15.8) | 0.583 | |
In-hospital mortality | 14 (73.7) | 14 (73.7) | 1.00 | |
Surgical intervention | 9 (47.4) | 8 (42.1) | 0.79 | |
Laboratory measurements | ||||
IL-6 d0 (pg/ml) | 58,385 [10,108, 206,000] | 59,812 [10,051, 600,000] | 0.181 | 1.2 |
IL-6 d1 (pg/ml) | 16,314 [461, 123,000] | 27,445 [30, 260,000] | ||
CRP d0 (mg/dl) | 14.5 [0.3, 47.1] | 16.3 [0.1, 46.9] | 0.817 | 5.8 |
CRP d1 (mg/dl) | 13.8 [0.7, 28.1] | 20.9 [1.1, 41.6] | ||
Lactate d0 (mmol/l) | 7.8 [1.0, 17.6] | 8.2 [0.8, 26.0] | 0.729 | 2.5 |
Lactate d1 (mmol/l) | 8.6 [1.2, 17] | 6.7 [0.9, 18] | ||
Nor d0 (mg/h) | 3.8 [0.9, 8.0] | 3.6 [0.0, 16.0] | 0.223 | 2.7 |
Nor d1 (mg/h) | 2.8 [0.4, 11.5] | 2.3 [0.3, 6.0] | ||